Probius: John Baldoni, Juan Cuevas
Probius, a Fremont, California-based tech company specializing in AI-enabled biological research and predictive healthcare, has appointed John Baldoni as CSO and Juan Cuevas as senior VP of marketing and business development.
Baldoni will remain chairman of the company's scientific advisory board as he begins his new role. He is also the cofounder and CSO of SaponiQx and CEO of the Atom Research Alliance. He has more than 40 years of experience in the pharmaceutical industry including with GlaxoSmithKline, where he founded an AI-driven drug discovery unit and was a member of the executive team for 11 years. He holds a BS in biochemistry and an MS and PhD in chemistry from Penn State University.
Cuevas joins Probius from Seer, where he was VP of customer experience and head of product marketing. Previously, he led product management for the reproductive health business unit at Thermo Fisher Scientific. He also held various roles at Affymetrix (acquired by Thermo Fisher). Cuevas holds a bachelor's degree in biochemistry from the Universidad Nacional de Cordoba I Argentina; a master's degree in biotechnology management from IE Business School; and a PhD from the University of Barcelona.
Probius said that both appointments are intended to help the company as it prepares to launch its Quantum Electrochemical Spectroscopy technology that analyzes the makeup of biological samples by representing biological information as a molecular vibration signal.